Works matching IS 10834389 AND DT 2022 AND VI 27 AND IP 4

Results: 11

Both family‐based Helicobacter pylori infection control and management strategy and screen‐and‐treat strategy are cost‐effective for gastric cancer prevention.

Published in:

Helicobacter, 2022, v. 27, n. 4, p. 1, doi. 10.1111/hel.12911

By:

Ma, Jing;
Yu, Miao;
Shao, Qiao‐Qiao;
Yu, Xue‐Chun;
Zhang, Chen;
Zhao, Jun‐Bo;
Yuan, Lin;
Qi, Ya‐Bin;
Hu, Ruo‐Bing;
Wei, Pei‐Ru;
Xiao, Wei;
Chen, Qi;
Jia, Bai‐Ling;
Chen, Chuan‐Liang;
Lu, Hong;
Ding, Song‐Ze

Publication type:

Article

Correlation between the intensity of Helicobacter pylori colonization and severity of gastritis: Results of a prospective study.

Published in:

Helicobacter, 2022, v. 27, n. 4, p. 1, doi. 10.1111/hel.12910

By:

Souissi, Salma;
Makni, Cyrine;
Belhadj Ammar, Leila;
Bousnina, Olfa;
Kallel, Lamia

Publication type:

Article

Influences of Helicobacter pylori infection on diversity, heterogeneity, and composition of human gastric microbiomes across stages of gastric cancer development.

Published in:

Helicobacter, 2022, v. 27, n. 4, p. 1, doi. 10.1111/hel.12899

By:

Xiao, Wanmeng;
Ma, Zhanshan

Publication type:

Article

SHP2/SPI1axis promotes glycolysis and the inflammatory response of macrophages in Helicobacter pylori‐induced pediatric gastritis.

Published in:

Helicobacter, 2022, v. 27, n. 4, p. 1, doi. 10.1111/hel.12895

By:

Li, Chuanying;
Lu, Changyun;
Gong, Liangju;
Liu, Jia;
Kan, Chen;
Zheng, Hong;
Wang, Siying

Publication type:

Article

Issue Information.

Published in:: Helicobacter, 2022, v. 27, n. 4, p. 1, doi. 10.1111/hel.12821
Publication type:: Article

Helicobacter bilis infection induces oxidative stress in and enhances the proliferation of human cholangiocytes.

Published in:

Helicobacter, 2022, v. 27, n. 4, p. 1, doi. 10.1111/hel.12908

By:

Yamashita, Mampei;
Adachi, Tomohiko;
Ono, Shinichiro;
Yoshino, Kyohei;
Imamura, Hajime;
Matsushima, Hajime;
Tanaka, Takayuki;
Kosaka, Taichiro;
Soyama, Akihiko;
Hidaka, Masaaki;
Kanetaka, Kengo;
Eguchi, Susumu

Publication type:

Article

Efficacy and safety of low‐dose rifabutin‐based 7‐day triple therapy as a third‐ or later‐line Helicobacter pylori eradication regimen.

Published in:

Helicobacter, 2022, v. 27, n. 4, p. 1, doi. 10.1111/hel.12900

By:

Inokuchi, Kazumi;
Mori, Hideki;
Matsuzaki, Juntaro;
Hirata, Kenro;
Harada, Yosuke;
Saito, Yoshimasa;
Suzuki, Hidekazu;
Kanai, Takanori;
Masaoka, Tatsuhiro

Publication type:

Article

Two novel sequence types of Helicobacter pylori strains: The first report from Turkey.

Published in:

Helicobacter, 2022, v. 27, n. 4, p. 1, doi. 10.1111/hel.12907

By:

Akar, Mustafa;
Saticioğlu, İzzet Burçin;
Karakaya, Emre;
Kayman, Tuba;
Abay, Seçil;
Solakoğlu, Tevfik;
Vale, Filipa F.;
Aydin, Fuat

Publication type:

Article

Probiotics mitigate Helicobacter pylori‐induced gastric inflammation and premalignant lesions in INS‐GAS mice with the modulation of gastrointestinal microbiota.

Published in:

Helicobacter, 2022, v. 27, n. 4, p. 1, doi. 10.1111/hel.12898

By:

He, Cong;
Peng, Chao;
Xu, Xinbo;
Li, Nianshuang;
Ouyang, Yaobin;
Zhu, Yin;
Lu, Nonghua

Publication type:

Article

Persistent advanced periductal fibrosis is associated with cagA‐positive Helicobacter pylori infection in post‐praziquantel treatment of opisthorchiasis.

Published in:

Helicobacter, 2022, v. 27, n. 4, p. 1, doi. 10.1111/hel.12897

By:

Phung, Hang Thi Thu;
Deenonpoe, Raksawan;
Suttiprapa, Sutas;
Mairiang, Eimorn;
Edwards, Steven W.;
Sripa, Banchob

Publication type:

Article

Optimization of vonoprazan‐amoxicillin dual therapy for eradicating Helicobacter pyloriinfection in China: A prospective, randomized clinical pilot study.

Published in:

Helicobacter, 2022, v. 27, n. 4, p. 1, doi. 10.1111/hel.12896

By:

Hu, Yi;
Xu, Xin;
Ouyang, Yao‐Bin;
He, Cong;
Li, Nian‐Shuang;
Xie, Chuan;
Peng, Chao;
Zhu, Zhen‐Hua;
Xie, Yong;
Shu, Xu;
Lu, Nong‐Hua;
Zhu, Yin

Publication type:

Article